Number of CTCs
|
0 - 4
|
5 ≤
|
P value
|
---|
Number of subjects
|
41
|
24
| |
---|
TNM: Stage
| | |
0.1586
|
Stage I
|
29
|
11
| |
Stage II
|
4
|
2
| |
Stage III
|
4
|
6
| |
Stage IV
|
4
|
5
| |
TNM: T category
| | |
0.2753
|
T1
|
26
|
10
| |
T2
|
5
|
3
| |
T3
|
5
|
4
| |
T4
|
5
|
7
| |
TNM: N category
| | |
0.0257 *
|
N0
|
27
|
12
| |
N1
|
5
|
0
| |
N2
|
4
|
2
| |
N3
|
5
|
10
| |
TNM: M category
| | |
0.2121
|
M0
|
37
|
19
| |
M1
|
4
|
5
| |
Main histological type
| | |
0.6844
|
Differentiated type
|
15
|
10
| |
Undifferentiated type
|
26
|
14
| |
Lymphatic invasion
| | |
0.3177
|
Lx
|
2
|
2
| |
L0
|
25
|
10
| |
L1
|
14
|
12
| |
Venous invasion
| | |
0.1293
|
Vx
|
2
|
2
| |
V0
|
26
|
9
| |
V1-2
|
13
|
13
| |
Surgery
| | |
0.2124
|
Curative resection
|
38
|
19
| |
Non-curative resection
|
1
|
3
| |
No resection
|
2
|
2
| |
Postoperative chemotherapy
| | |
0.1672
|
Presence
|
15
|
13
| |
Absence
|
26
|
11
| |
- * * Significant difference.